FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter GLENMARK PHARMS LTD ANDA 212317
Letter
ANDA 212317
GLENMARK PHARMS LTD
FDA.report
›
FDA Drug Approvals
›
GLENMARK PHARMS LTD
›
ANDA 212317
›
Letter
Application #212317
Documents
Letter
2021-04-13
Application Sponsors
ANDA 212317
GLENMARK PHARMS LTD
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.